Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

Clinical trial NCT06869265 · RECRUITING

Trial details

NCT number: NCT06869265
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)High Risk Acute Myeloid Leukemia(AML)Relapsed/Refractory Acute Myeloid Leukemia (AML)

Start date: 2025-05-01
Primary completion: 2028-04-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.